Since there is a bullish harami cross with a doji as a result there may also be more added pressure to shake some shares loose.
I do agree that Elite is being investigated by other pharmaceutical companies to see what potential future impacts Elite could have as a business partner. SunGen being one, HumanWell the other, as well as possibly a few other entities not mentioned... yet.
As 50 day MA average rides with the 200 day MA it is only a matter of time before the FDA approves one of these ANDAs.